FindMyKOL

Alice Lee, MD

Enriched profile

Director, Early Phase Clinical Trials program and Director, Pediatric Sarcoma program at the Children's Hospital at Montefiore Einstein · Children's Hospital at Montefiore

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyHematology / OncologyFocusGlioma+18
Active KOLFindMyKOL type: RegionalLatest publicationNone indexedOnline presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Alice Lee is Director, Early Phase Clinical Trials program and Director, Pediatric Sarcoma program at the Children's Hospital at Montefiore Einstein at Children's Hospital at Montefiore. ClinicalTrials.gov lists 25 registered studies with this person as an investigator.

Data verified 27 Oct 2026

Overview

Updated 28 Oct 2026

Alice Lee, MD, is Director, Early Phase Clinical Trials program and Director, Pediatric Sarcoma program at the Children's Hospital at Montefiore Einstein. It also documents an investigator role on 25 registered clinical trials, industry payments reported by 6 companies.

  • Top research focus: Glioma
  • 25 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 6 companies

Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Sarcoma8 trialsComa8 trialsNeuroblastoma4 trialsLymphoma3 trialsNeuro-Oncology / Glioma3 trialsGlioma3 trialsMedulloblastoma3 trialsSarcoma, Ewing3 trialsRhabdomyosarcoma3 trialsMyosarcoma3 trialsNeoplasms, Germ Cell and Embryonal3 trialsTeratoma3 trialsHodgkin Disease2 trialsCentral Nervous System Neoplasms2 trialsWilms Tumor2 trialsHistiocytosis2 trialsPheochromocytoma2 trialsEndodermal Sinus Tumor2 trialsCarcinoma, Embryonal2 trialsChoriocarcinoma2 trialsGanglioneuroblastoma2 trialsLeukemia (AML/ALL/CML/CLL)2 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma2 trialsLymphoma, Non-Hodgkin1 trialEpendymoma1 trialNeuroectodermal Tumors, Primitive, Peripheral1 trialRhabdoid Tumor1 trialHepatoblastoma1 trialKidney Cancer / RCC1 trialMDS / MPN1 trialCarcinoma in Situ1 trialDesmoid Tumors1 trialNeuroma1 trialFibroma1 trialGanglioneuroma1 trialNephroma, Mesoblastic1 trialSeminoma1 trialNeural Tube Defects1 trialTeratoma, Ovarian1 trialHepatobiliary Cancer1 trialGerminoma1 trialRhabdomyosarcoma, Alveolar1 trialRhabdomyosarcoma, Embryonal1 trialRecurrence1 trialParaganglioma1 trial

Research focus

OpenAlex concept fingerprint
GliomaNeuro-Oncology / GliomaNeuroblastomaSarcomaSarcoma, EwingCentral Nervous System NeoplasmsEpendymomaHepatoblastomaHodgkin DiseaseLymphomaLymphoma, Non-HodgkinMedulloblastomaMyosarcomaNeuroectodermal Tumors, Primitive, PeripheralParagangliomaPheochromocytomaRhabdoid TumorRhabdomyosarcomaWilms Tumor

Drugs & molecules

across trials, industry payments and publications
Ogsiveogeneric · NirogacestatClinical trials—Industry payments2Publications—Vraylargeneric · CariprazineClinical trials—Industry payments2Publications—Sarclisageneric · IsatuximabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Medtronic, Inc.Clinical trials—Industry payments15Children's Oncology GroupClinical trials12Industry payments—National Cancer Institute (NCI)Clinical trials5Industry payments—H. Lee Moffitt Cancer Center and Research InstituteClinical trials3Industry payments—Abbvie Inc.Clinical trials—Industry payments2Montefiore Medical CenterClinical trials2Industry payments—SpringWorks Therapeutics, Inc.Clinical trials—Industry payments2Concord Repatriation General HospitalClinical trials1Industry payments—Genzyme CorporationClinical trials—Industry payments1Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)Clinical trials1Industry payments—Nationwide Children's HospitalClinical trials1Industry payments—W. L. Gore & Associates, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
0h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
25clinical trials

Investigator role on registered studies.

View trials ↓
6companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 28 Oct 2026

Listed as an investigator on 25 registered studies on ClinicalTrials.gov. The most recent:

All 25 trial records: search, sort and filter.Explore →

Industry payments

Updated 28 Oct 2026

6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 6 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Background & recognition

Updated 28 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.